Medication info

Pagliflozin Tablets 5 mg (Dapagliflozin Monohydrate Combination)

Prescription medicationTabletOralExpired
Ingredient · strength
Dapagliflozin Anhydrous Lactose Mixture›7.635mg / 1 tablet
Manufacturer / importer
Anguk Pharmaceutical Co., Ltd.
Appearance
Yellow, round, film-coated tablets that are convex on both sides
Packaging
28 tablets/box [7 tablets/PTP X 4]
Approval status
Expired

MFDS item code 202005371 · Approved 2020.07.23

This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of diabetes medication, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of the day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Anguk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be taken alone, but if blood sugar control is difficult with monotherapy, it may be used in combination with other diabetes medications such as metformin, sulfonylureas, insulin, or sitagliptin. Furthermore, it can be added when adequate blood sugar control cannot be achieved with multiple drugs. It assists in effective blood sugar control tailored to various treatment situations of the patient.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of diabetes medication, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of the day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in certain patients. First, patients allergic to the active ingredient or excipients should not take this medication. Second, it should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Third, patients with problems in lactose digestion or genetic conditions such as galactose intolerance should not take this medication. Fourth, it is not used in patients undergoing dialysis. This medication should be administered cautiously to patients with low fluid volume or poor kidney function. It may lower blood pressure or affect kidney function, so caution is particularly warranted in the elderly or patients taking diuretics. Before administration, the patient's fluid status and kidney function should be assessed, and blood pressure and kidney function should be continuously monitored during treatment. This medication contains colorants Yellow No. 4 and Yellow No. 5, and patients allergic to these components should be cautious. During the treatment, side effects such as genital infections, urinary tract infections, hypoglycemia, low fluid volume, and diabetic ketoacidosis may occur. Genital infections are particularly more common in women, and if symptoms of infection develop, immediate treatment should be sought. Hypoglycemia may occur more frequently when taken alongside insulin or sulfonylureas, so be attentive to hypoglycemic symptoms when using these medications in combination. Dehydration or low blood pressure may develop due to decreased fluid volume, so symptoms of dehydration or changes in blood pressure should be closely monitored. Diabetic ketoacidosis may occur even when blood sugar is not significantly elevated, so if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing appear, immediate consultation with healthcare professionals is advised. This medication may affect kidney function, so patients with impaired kidney function should have their renal status evaluated before administration and should undergo regular kidney function tests during treatment. Pregnant or breastfeeding women are advised not to take this medication, and if pregnancy is confirmed, it should be discontinued immediately. In the case of overdose, there is no specific antidote, so it is necessary to receive appropriate treatment based on symptoms. Caution may be needed for hypoglycemia while driving or operating machinery during the use of this medication, so symptoms should be well monitored. The medicine should be stored out of reach of children and kept in its original container for safety.

Side effects

Vulvovaginitis, balanitis, and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, lumbago, dysuria, polyuria, nocturia, interstitial nephritis, pruritus of the vulva, genital itching, increased hematocrit, decreased creatinine clearance at the beginning of treatment, dyslipidemia, increased blood creatinine at the beginning of treatment, elevated blood urea, weight loss, rash, angioedema, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, gastroesophageal reflux disease, epigastric pain, diverticulosis, intestinal perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, paresthesia, cerebral infarction, nerve compression, asthenia, pain, ligament sprain, traffic accident, drug overdose, ankle fracture, hand fracture, pelvic fracture, meniscal injury, thoracic vertebra fracture, tibia fracture, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, bile duct stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, sensory impairment, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, Pica, headache, nasopharyngitis, upper respiratory infection, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like symptoms, chest pain, fatigue, chest discomfort, peripheral edema, generalized edema, hunger, vaginal discharge, irregular menstruation, itching, urticaria, sweating, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container to prevent entry of air or moisture. The storage temperature should be maintained at room temperature between 1 to 30 degrees. This will help preserve the medication's effectiveness over time.

Appearance and packaging

Appearance

Yellow, round, film-coated tablets that are convex on both sides

Package unit

28 tablets/box [7 tablets/PTP X 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.